SAN DIEGO,kage shadow of the ninja remake Nov. 05, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that it will report third quarter 2020 financial results and provide a corporate update after the market close on Thursday, November 12, 2020.

Conference Call and Webcast Details:

Thursday, November 12th @ 5:00 p.m. EST / 2:00 p.m. PST

Domestic: 844-358-9116

International: 209-905-5951

Conference ID: 4549288

Webcast:

http://investors.atyrpharma.com/events-and-webcasts

Abo

ut aTyr

aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in inflammatory lung diseases. For more information, please visit

http://www.atyrpharma.com

.

Contact:

Ashlee Dunston

Director, Investor Relations and Corporate Communications

aTyr Pharma

[email protected]

View comments

• ·International Container Terminal Services, Inc. to Host Earnings Call
• ·Is Old Second Bancorp, Inc. (NASDAQ:OSBC) A Volatile Stock?
• ·Largest Mutual Funds Give Loyal Shareholders Unwanted Capital Gains Distributions
• ·Mitt Romney to visit 'Live With Kelly'
• ·Global 5G infrastructure market size to reach USD 47.6 Billion by 2027
• ·BMW E30 M3 vs Audi RS2 Avant: Which Would You Rather Own?
• ·Kim Kardashian's Met Gala After Party Was a Slice of Pizza and a Hotel Room Photo Shoot
• ·People in the News—Jan. 2, 2019—Arnold & Porter
• ·Sun Summit Minerals Phase 2 Drilling Update and Completion of IP Survey at the Buck Property
• ·Shire plc : Rule 2.9 Announcement
• ·Is Matador Resources Company’s (NYSE:MTDR) Balance Sheet Strong Enough To Weather A Storm?
• ·Pompeo says cooperation with Israel over Syria and Iran to continue
• ·How Does Credit Acceptance's (NASDAQ:CACC) P/E Compare To Its Industry, After Its Big Share Price Gain?
• ·What You Must Know About PLC S.p.A.’s (BIT:PLC) Financial Strength
• ·DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Apogee Enterprises, Inc. (APOG) and Lead Plaintiff Deadline - January 4, 2019
• ·Lessons to Investors From Bitcoin's First Decade